Form D · Biotechnology
ENDRA Life Sciences Inc.
Ann Arbor, MI · CIK 0001681682
Offering snapshot reported Oct 24, 2025 · SEC filing
- Reported sold
- $14.4M Offering amount: $14.4M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $200K Reported outside-investor minimum
- First sale
- Oct 10, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 24, 2025 | Initial | $14,402,880 | No comparison | 6 | SEC filing |
| Dec 20, 2019 | Initial | $8,555,000 | No comparison | 151 | SEC filing |
| Jul 31, 2019 | Initial | $2,805,000 | No comparison | 86 | SEC filing |
| Jul 3, 2018 | Initial | $1,077,000 | No comparison | 18 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06c
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $295K
- Finders' fees
- $0
- Form D file number
- 021-562053
Reflects proceeds from the sale of shares of the Company's common stock, par value $0.0001 per share and/or pre-funded warrants and common stock purchase warrants, if all such warrants were exercised.
Prefunded and Common Warrants to purchase shares of Common Stock
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Lucid Capital Markets, LLC | 000140345 |
Source: Form D, filed Oct 24, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Louis J. Basenese | Director |
| Anthony Di Giandomenico | Director |
| Sanjiv S. Gambhir | Director |
| Michael Harsh | Director |
| Richard Jacroux | Executive |
| Francois R. Michelon | Director, Executive |
| Michael Thornton | Executive |
| Alexander Tokman | Director, Executive |
| David R. Wells | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3600 Green Court Suite 350
Ann Arbor, MI, 48105
Ann Arbor, MI, 48105